Inflammatory bowel diseases: Current problems and future tasks

Table 1 Contains patients’ demographics and disease characteristics

	UC (38, 24 m)		CD(26, 16 m)
Age, yr	Extension	Age, yr	Extension
18-80	Proctitis, 12	16-73	Ileo-colonic 15
	Sub-total, 11		Colitis, 5
	Left, 8		Universal, 4
	Pancolitis, 6		Ileitis, 2
	IPAA, 1

UC: Ulcerative colitis; CD: Crohn’s Disease; IPAA: Ileo-pouch anal anastomosis.

Table 2 Gives the frequencies of use of the main drugs n (%)

Ulcerative colitis	Crohn’s disease
Mesalamines 33 (86)	18 (69)
Steroids 21 (55)	5 (19)
Thiopurines 14 (36)	8 (30)
Biologics 1(2.6)	1 (3.8)

Table 3 Illustrates the distribution of the main extra-intestinal affections

	n	Familial	Personal
Ulcerative colitis
Psoriasis	2	0	2
Inflammatory bowel disease	3	3	0
Asthma	2	1	1
Rheumatoid Arthritis	2	0	2
Crohn’s disease
Psoriasis	4	3	1
Inflammatory bowel disease	3	3	0
Asthma	1	1	0
Rheumatoid Arthritis	1	1	0